|
Market Closed -
Nasdaq
16:00:00 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 0.3929 USD | +3.56% |
|
-16.40% | -78.05% |
| Market Cap | 73.82M 66.01M 61.07M 55.3M 103M 7.02B 105M 735M 291M 3.67B 277M 271M 11.63B | P/E 2026 * |
-0.45x | P/E 2027 * | -0.58x |
|---|---|---|---|---|---|
| Enterprise Value | -127M -113M -105M -94.81M -177M -12.04B -180M -1.26B -498M -6.3B -475M -465M -19.94B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
76.92% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NMRA | Delayed | |
CBOE
| NMRA | Real-time |
Last Transcript: Neumora Therapeutics, Inc.
| 1 day | +3.56% | ||
| 1 week | -16.40% | ||
| Current month | -34.10% | ||
| 1 month | -42.02% | ||
| 3 months | -73.63% | ||
| 6 months | -82.54% | ||
| Current year | -78.05% |
| 1 week | 0.37 |  | 0.48 |
| 1 month | 0.32 | | 0.75 |
| Current year | 0.32 | | 3.65 |
| 1 year | 0.32 | | 3.65 |
| 3 years | 0.32 | | 21 |
| 5 years | 0.32 | | 21 |
| 10 years | 0.32 | | 21 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joshua Pinto
CEO | Chief Executive Officer | 43 | 2026-08-13 |
Michael Milligan
DFI | Director of Finance/CFO | 54 | 2025-02-13 |
Andrew Lam
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Berns
CHM | Chairman | 59 | 2019-12-31 |
Kristina Burow
BRD | Director/Board Member | 53 | 2019-12-31 |
May Kin Ho
BRD | Director/Board Member | 73 | 2021-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/21/26 | Exercice | Chief Operating Officer | 124,824 | 0.0674% | ||
| 8/20/26 | Free | Chief Executive Officer | 500,000 | 0.2699% | ||
| 8/20/26 | Free | Chief Administrative Officer | 375,000 | 0.2024% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.56% | -16.40% | -85.06% | -96.80% | 73.82M | |
| +0.88% | -0.34% | +40.64% | +73.05% | 65.28B | |
| -0.13% | -0.15% | +9.63% | +77.21% | 54.57B | |
| -0.68% | +0.93% | +9.02% | +100.51% | 53.59B | |
| -2.06% | +2.90% | +24.07% | +48.36% | 45.03B | |
| -1.79% | +0.19% | +19.32% | +123.62% | 42.17B | |
| -1.65% | +0.96% | +237.56% | +823.66% | 39.42B | |
| -2.26% | -4.14% | +15.38% | +45.53% | 32.71B | |
| -2.70% | -10.77% | +19.80% | -6.47% | 24.01B | |
| +0.52% | +14.83% | +59.79% | +48.88% | 26.5B | |
| Average | -0.63% | +0.50% | +35.01% | +123.75% | 38.33B | |
| Weighted average by Cap. | -0.90% | +2.27% | +45.60% | +148.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -169M -151M -139M -126M -236M -16.04B -240M -1.68B -664M -8.39B -633M -619M -26.56B | -156M -139M -129M -117M -218M -14.82B -222M -1.55B -613M -7.75B -585M -572M -24.54B |
| Net Debt | -200M -179M -166M -150M -281M -19.07B -286M -2B -789M -9.97B -752M -736M -31.57B | -280M -250M -231M -210M -392M -26.62B -399M -2.79B -1.1B -13.92B -1.05B -1.03B -44.09B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-26 | US$0.3929 | +3.56% | 512,157 |
| 26-10-23 | US$0.3794 | -6.48% | 835,857 |
| 26-10-22 | US$0.4057 | -2.48% | 865,065 |
| 26-10-21 | US$0.4160 | -10.54% | 1,577,542 |
| 26-10-20 | US$0.4650 | -1.06% | 974,530 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NMRA Stock
Select your edition
All financial news and data tailored to specific country editions
